Charles J Casamento insider trades

Open-market stock purchases and sales by Charles J Casamento, Director at Eton Pharmaceuticals, Inc, from SEC Form 4 filings since Jan 22, 2010.

Track record: 100% of 6 scored buys are up 5% or more since purchase, averaging +99%.

Recent trades

DateStockTradeValue
Jan 12, 2026ETON Eton Pharmaceuticals, IncBought (not open market)—
Jan 12, 2026ETON Eton Pharmaceuticals, IncBought (not open market)—
Dec 12, 2025RLMD Relmada Therapeutics, IncBought (not open market)—

Companies traded

  • ETON Eton Pharmaceuticals, Inc: 2 buys, last Jan 12, 2026
  • RLMD Relmada Therapeutics, Inc: 6 buys, 21 sales, last Dec 12, 2025
  • GTBP GT Biopharma, Inc: other filings, last Sep 4, 2025
  • PXMD PaxMedica, Inc: other filings, last Mar 12, 2024
  • FWBI First Wave BioPharma, Inc: 2 sales, last Jan 2, 2024
  • AZRX AzurRx BioPharma, Inc: 1 buy, last Jan 4, 2021
  • ISCO.OB International Stem Cell Corp: other filings, last Jun 21, 2018
  • ISCO International Stem Cell Corp: other filings, last Dec 31, 2015
  • ASTX Astex Pharmaceuticals, Inc: 3 sales, last Oct 11, 2013
  • VVUS Vivus Inc: 4 sales, last Jan 25, 2013
  • COR Cortex Pharmaceuticals Inc/de/: other filings, last Aug 3, 2012
  • SUPG Supergen Inc: other filings, last Jun 16, 2011

Get free alerts when Charles J Casamento files a new trade →